Ibalizumab, active against highly resistant HIV, now approved in US
Statin users have lower rates of many types of cancer
The vaginal ring: more HOPE to the DREAM? Higher adherence and better effectiveness seen in open-label ring studies
Efavirenz may undermine effectiveness of the vaginal ring contraceptive
Average time from HIV diagnosis to treatment fell to six days in 2016 in San Francisco
Transgender women in Los Angeles are more likely to be in high HIV incidence clusters than any other group
PrEP use growing in US, but not reaching all those in need
Biktarvy combo maintains viral suppression after switching therapy
Same-day treatment start improves retention in care and viral suppression in Lesotho
New HIV infections halved after scale-up of HIV treatment and circumcision in Uganda's hardest-hit district
Twice-daily dolutegravir is safe and effective when used alongside TB treatment
Antiretroviral drug levels in hair strongly predict viral suppression
One-month TB prevention regimen just as effective as 9-month regimen
US genotyping survey finds rapid HIV infection rate in young and Latino gay men
New TB screening methods cut deaths in people with HIV
Study finds that women are much more vulnerable to HIV infection during pregnancy and in the months after giving birth
Experimental antibody plus TLR7 agonist maintains viral suppression in monkeys
